Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
F-Equine Vac
- Development stage
- Unknown
- Lead developer
- Merck Animal Health
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
F-Equine Vac is an inactivated veterinary vaccine developed by Vetal Company for the active immunization of horses against equine influenza. The vaccine contains inactivated equine influenza virus (EIV) subtypes EIV-1 (H7N7) and EIV-2 (H3N8). It is administered intramuscularly as a 2 ml dose, with a primary vaccination schedule consisting of two doses spaced 3 to 4 weeks apart, followed by annual booster vaccinations to maintain protective immunity.
- Brand names
- F-Equine Vac
- Other names
- Inactive Influenza Horse Vaccine
02
Targets
HA (Hemagglutinin)H7 HA (Influenza A hemagglutinin H7)
Beyond the preview
Go deeper on F-Equine Vac.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on F-Equine Vac.